Asia-Pacific Animal Vaccine Market
Asia-Pacific Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)
Industry Overview
Asia-Pacific animal vaccine market was valued at $2,462.6 million in 2025 and is projected to reach $5,289.8 million by 2035, growing at a CAGR of 8.0% during the forecast period (2026–2035). The Asia-Pacific animal vaccine market is experiencing steady expansion as governments and livestock producers prioritize disease prevention, biosecurity, and sustainable animal production. Growth is being driven by rising demand for animal protein, increasing incidence of transboundary and zoonotic diseases, and strengthening veterinary healthcare infrastructure across emerging economies. Countries such as China, India, Japan, and Australia are intensifying vaccination programs to protect swine, poultry, cattle, and aquaculture populations from economically significant diseases. Technological advancements in vaccine development, including recombinant and vectored platforms, are enhancing vaccine efficacy, safety, and disease coverage. Increasing awareness of food safety, export quality standards, and antimicrobial resistance is also accelerating the shift toward preventive vaccination over therapeutic treatment. As Asia-Pacific remains a global hub for livestock and aquaculture production, animal vaccination is becoming a critical component of herd health management and long-term productivity improvement across the region.
Market Dynamics
Rising Incidence of Livestock and Zoonotic Diseases
Frequent outbreaks of diseases such as African swine fever, avian influenza, foot-and-mouth disease, and Newcastle disease have highlighted the need for robust vaccination strategies across Asia-Pacific. Governments and veterinary authorities are strengthening national immunization programs and surveillance systems to minimize economic losses and protect food security. Growing concerns over zoonotic disease transmission are further encouraging investment in preventive veterinary healthcare, driving consistent demand for animal vaccines.
Expanding Livestock Production and Protein Consumption
Rapid urbanization, population growth, and rising disposable incomes are increasing consumption of meat, dairy, and seafood products across Asia-Pacific. To meet this demand, livestock and aquaculture producers are scaling operations and adopting structured vaccination schedules to maintain herd immunity and productivity. Commercial farming practices and integration of advanced veterinary services are contributing to higher vaccine penetration, particularly in China, India, and Southeast Asian markets.
Market Segmentation
- Based on the type, the market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines, and other animal vaccines.
- Based on the technology, the market is segmented into live attenuated vaccine, killed/inactive vaccine, recombinant vaccine, vectored vaccine, subunit vaccine, DNA vaccine, chimeric vaccine, and others.
Poultry Vaccines Segment to Lead the Market with the Largest Share
The poultry vaccines segment is projected to hold the largest share in the Asia-Pacific animal vaccine market, supported by the region’s dominant role in global poultry production and export. High-density poultry farming increases susceptibility to infectious diseases such as avian influenza and infectious bronchitis, prompting widespread adoption of routine vaccination programs. Government-backed disease control initiatives and biosecurity regulations are further strengthening vaccine uptake. Additionally, growing demand for affordable protein sources and expanding commercial poultry operations continue to reinforce the leading position of this segment across the region.
Live Attenuated Vaccines: A Key Technology Segment Driving Market Growth
Live attenuated vaccines represent a major technology segment in the Asia-Pacific animal vaccine market due to their strong immunogenic response and long-lasting protection. These vaccines are widely used in poultry and livestock immunization programs because of their cost-effectiveness and ability to induce rapid immunity. However, recombinant, subunit, and vectored vaccines are gaining traction as manufacturers invest in safer and more targeted solutions to address evolving disease strains. Continuous research and development activities are expected to accelerate the adoption of advanced vaccine technologies, further strengthening regional market growth.
Regional Outlook
Asia-Pacific animal vaccine market is further divided by countries, including China, Japan, South Korea, India, Australia & New Zealand, ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and others), and the Rest of Asia-Pacific.
China Dominates the Market with Major Share
China holds a leading position in the Asia-Pacific animal vaccine market, supported by its vast livestock population and strong government focus on animal disease control. As one of the world’s largest producers of pork and poultry, the country maintains extensive vaccination programs to prevent outbreaks such as African swine fever, foot-and-mouth disease, and avian influenza. Regulatory oversight and biosecurity measures implemented by the Ministry of Agriculture and Rural Affairs of the People's Republic of China have strengthened nationwide immunization coverage and improved farm-level disease monitoring. In addition, rapid modernization of large-scale commercial farms and the adoption of advanced vaccine technologies, including recombinant and inactivated vaccines, are enhancing disease prevention efficiency. Domestic animal health companies are expanding production capacity and investing in R&D to develop cost-effective and high-efficacy vaccines tailored to local disease patterns. With increasing emphasis on food safety, export quality standards, and prevention of transboundary animal diseases, China’s dominant position in the Asia-Pacific animal vaccine market is expected to remain strong over the forecast period.
Market Players Outlook
The major companies operating in the Asia-Pacific animal vaccine market include Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In July 2025, Zoetis expanded its livestock vaccine portfolio across Asia-Pacific with the introduction of enhanced swine and poultry vaccines designed to improve herd immunity and disease resilience in high-density farming environments. The initiative focuses on strengthening distribution networks in China, India, and Southeast Asia.
- In May 2025, Boehringer Ingelheim Animal Health announced the expansion of its recombinant and vectored vaccine production capabilities in Asia-Pacific to address rising demand for next-generation animal vaccines. The development aims to support regional disease prevention programs and improve supply chain efficiency.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Asia-Pacific animal vaccine Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Asia-Pacific Animal Vaccine Market Sales Analysis – Type | Technology ($ Million)
- Animal Vaccine Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Asia-Pacific Animal Vaccine Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Asia-Pacific Animal Vaccine Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Asia-Pacific Animal Vaccine Market: Impact Analysis
- Market Opportunities
- Opportunities For Asia-Pacific Animal Vaccine Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Asia-Pacific Animal Vaccine Market Revenue and Share by Manufacturers
- Animal Vaccine Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Elanco Animal Health Incorporated
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Phibro Animal Health Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Virbac S.A.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zoetis Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Elanco Animal Health Incorporated
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Asia-Pacific Animal Vaccine Market Sales Analysis by Type ($ Million)
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Aquaculture Vaccines
- Companion Animal Vaccines
- Other
- Asia-Pacific Animal Vaccine Market Sales Analysis by Technology ($ Million)
- Live Attenuated Vaccine
- Killed/Inactive Vaccine
- Recombinant Vaccine
- Vectored Vaccine
- Subunit Vaccine
- DNA Vaccine
- Chimeric Vaccine
- Others
- Regional Analysis
- Asia-Pacific Animal Vaccine Market Sales Analysis – Type | Technology | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
- Rest of Asia-Pacific
- Company Profiles
- Boehringer Ingelheim Animal Health
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceva Santé Animale
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- China Animal Husbandry Industry Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Elanco Animal Health Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hester Biosciences Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HIPRA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Indian Immunologicals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Intas Pharmaceuticals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jinyu Bio-Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Komipharm International Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kyoritsu Seiyaku Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- National Veterinary Joint Stock Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nippon Zenyaku Kogyo Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Phibro Animal Health Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PT Medion Farma Jaya
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tianjin Ringpu Bio-Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vetoquinol S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Virbac S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zoetis Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim Animal Health
1. Asia-Pacific Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Asia-Pacific Porcine Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Asia-Pacific Poultry Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Asia-Pacific Livestock Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Asia-Pacific Aquaculture Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Asia-Pacific Companion Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Asia-Pacific Other Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Asia-Pacific Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
9. Asia-Pacific Live Attenuated Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Asia-Pacific Killed/Inactivated Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Asia-Pacific Recombinant Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Asia-Pacific Vectored Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Asia-Pacific Subunit Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Asia-Pacific DNA Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Asia-Pacific Chimeric Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Asia-Pacific Others Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Asia-Pacific Animal Vaccine Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Asia-Pacific Animal Vaccine Market Research and Analysis by Type, 2025–2035 ($ Million)
19. Asia-Pacific Animal Vaccine Market Research and Analysis by Technology, 2025–2035 ($ Million)
1. Asia-Pacific Animal Vaccine Market Share by Type, 2025 Vs 2035 (%)
2. Asia-Pacific Porcine Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
3. Asia-Pacific Poultry Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
4. Asia-Pacific Livestock Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
5. Asia-Pacific Aquaculture Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
6. Asia-Pacific Companion Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
7. Asia-Pacific Other Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
8. Asia-Pacific Animal Vaccine Market Research and Analysis by Technology, 2025 Vs 2035 (%)
9. Asia-Pacific Live Attenuated Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
10. Asia-Pacific Killed/Inactivated Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
11. Asia-Pacific Recombinant Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
12. Asia-Pacific Vectored Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
13. Asia-Pacific Subunit Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
14. Asia-Pacific DNA Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
15. Asia-Pacific Chimeric Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
16. Asia-Pacific Others Animal Vaccine Market Share by Region, 2025 Vs 2035 (%)
17. Asia-Pacific Animal Vaccine Market Share by Region, 2024 Vs 2035 (%)
18. China Animal Vaccine Market Size, 2025–2035 ($ Million)
19. Japan Animal Vaccine Market Size, 2025–2035 ($ Million)
20. South Korea Animal Vaccine Market Size, 2025–2035 ($ Million)
21. India Animal Vaccine Market Size, 2025–2035 ($ Million)
22. Australia & New Zealand Animal Vaccine Market Size, 2025–2035 ($ Million)
23. ASEAN Countries Animal Vaccine Market Size, 2025–2035 ($ Million)
24. Rest of Asia-Pacific Animal Vaccine Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Asia-Pacific Animal Vaccine Market in 2025 is estimated to be around $2,462.6 million.
China holds the largest share in the Asia-Pacific Animal Vaccine Market.
Leading players in the Asia-Pacific Animal Vaccine Market Include Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc., among others.
The Asia-Pacific Animal Vaccine Market is expected to grow at a CAGR of 8.0% from 2026 to 2035.
The Asia-Pacific Animal Vaccine market growth is driven by rising livestock population, increasing prevalence of animal diseases, and growing demand for improved animal healthcare.
